Immunocytochemical localization of sphingolipid activator protein 2 (SAP-2) in normal and SAP-deficient fibroblasts.
The intracellular localization of sphingolipid activator protein 2 (SAP-2) was determined immunocytochemically using an antiserum raised against a SAP-2 preparation from Gaucher spleen. The immunolabeling indicated that SAP-2 was largely localized in the lysosomes of fibroblasts from normal individuals. In some lysosomes the labeling was greatest around the perimeter of the matrix, suggesting an association between the activator and lysosomal membrane components. The labeling technique was also applied to fibroblasts from a patient with a unique sphingolipid storage disorder. Consistent with immunoblotting studies on electrophoretograms, both the patient and his affected fetal sibling were found to be deficient in immunoreactive SAP-2.
Paton
B C
BC
Department of Chemical Pathology, Adelaide Medical Center for Women and Children, Adelaide Children's Hospital Campus, Australia.
Hughes
J L
JL
Harzer
K
K
Poulos
A
A
D002478:Cells, Cultured; D005347:Fibroblasts / Q000032:analysis* / Q000648:ultrastructure; D006023:Glycoproteins / Q000032:analysis* / Q000172:deficiency; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D008247:Lysosomes / Q000032:analysis*; D008297:Male; D008854:Microscopy, Electron; D049231:Saposins; D049128:Sphingolipid Activator Proteins; D013106:Sphingolipidoses / Q000378:metabolism
D006023:Glycoproteins; C483345:PSAP protein, human; D049231:Saposins; D049128:Sphingolipid Activator Proteins